[Drug-induced immune hemolytic anemias].
D000327:Adsorption; D000743:Anemia, Hemolytic / Q000139:chemically induced*; D000744:Anemia, Hemolytic, Autoimmune / Q000209:etiology; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000936:Antigen-Antibody Complex; D001323:Autoantibodies; D001557:Benzenesulfonates / Q000009:adverse effects; D002462:Cell Membrane; D003298:Coombs Test; D064420:Drug-Related Side Effects and Adverse Reactions; D004912:Erythrocytes; D006241:Haptens; D006801:Humans; D008750:Methyldopa / Q000009:adverse effects; D008970:Molecular Weight; D010406:Penicillins / Q000009:adverse effects; D010653:Phenylbutazone / Q000009:adverse effects; D011802:Quinidine / Q000009:adverse effects; D013499:Surface Properties; D014149:Tranquilizing Agents / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D000936:Antigen-Antibody Complex; D001323:Autoantibodies; D001557:Benzenesulfonates; D006241:Haptens; D010406:Penicillins; D014149:Tranquilizing Agents; D008750:Methyldopa; D010653:Phenylbutazone; D011802:Quinidine
Medikamentös bedingte immunhämolytische Anämien.